关注
Grigore-Aristide Gafencu
Grigore-Aristide Gafencu
其他姓名Grigore Gafencu
Bioinformatician, Oxford Molecular Diagnostics Centre, Department of Oncology, University of Oxford
在 oncology.ox.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer
F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ...
J Gastrointestin Liver Dis 24 (4), 435-443, 2015
1012015
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
B Petrushev, S Boca, T Simon, C Berce, I Frinc, D Dima, S Selicean, ...
International journal of nanomedicine, 641-660, 2016
522016
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome
A Jurj, L Pop, B Petrushev, S Pasca, D Dima, I Frinc, D Deak, ...
Critical Reviews in Clinical Laboratory Sciences 55 (7), 501-515, 2018
312018
Lactate–A new frontier in the immunology and therapy of prostate cancer
I Nenu, GA Gafencu, T Popescu, G Kacso
Journal of cancer research and therapeutics 13 (3), 406-411, 2017
302017
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging
NA Jakobsen, S Turkalj, AGX Zeng, B Stoilova, M Metzner, S Rahmig, ...
Cell Stem Cell 31 (8), 1127-1144. e17, 2024
202024
Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia?
S Boca, C Berce, A Jurj, B Petrushev, L Pop, GA Gafencu, S Selicean, ...
Medical Hypotheses 109, 42-45, 2017
202017
PARP inhibitors in acute myeloid leukaemia therapy: How a synthetic lethality approach can be a valid therapeutic alternative
GA Gafencu, CI Tomuleasa, G Ghiaur
Medical hypotheses 104, 30-34, 2017
152017
Transforming growth factor β‐mediated micromechanics modulates disease progression in primary myelofibrosis
P Teodorescu, S Pasca, A Jurj, G Gafencu, JP Joelsson, S Selicean, ...
Journal of Cellular and Molecular Medicine 24 (19), 11100-11110, 2020
142020
Fibroblast dynamics as an in vitro screening platform for anti‐fibrotic drugs in primary myelofibrosis
C Tomuleasa, S Selicean, G Gafencu, B Petrushev, L Pop, C Berce, A Jurj, ...
Journal of Cellular Physiology 233 (1), 422-433, 2018
142018
MicroRNAs in liver malignancies. Basic science applied in surgery.
M Muresan, F Zaharie, A Bojan, I Frinc, D Dima, S Selicean, GA Gafencu, ...
Journal of BU ON.: Official Journal of the Balkan Union of Oncology 20 (2 …, 2015
142015
The predictive role of modified early warning score in 174 hematological patients at the point of transfer to the intensive care unit
C Constantinescu, S Pasca, S Iluta, G Gafencu, M Santa, C Jitaru, ...
Journal of Clinical Medicine 10 (20), 4766, 2021
112021
Clinicopathological analysis of a case series of peripheral T-cell lymphomas, not otherwise specified, of lymphoepithelioid variant (Lennert's lymphoma). A Central European …
GA Gafencu, SE Selicean, B Petrushev, A Cucuianu, D Dima, I Frinc, ...
Human Pathology 53, 192-194, 2016
92016
Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging
NA Jakobsen, S Turkalj, AGX Zeng, B Stoilova, M Metzner, MS Nagree, ...
bioRxiv, 2023.09. 12.557322, 2023
82023
Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved
M Aksöz, GA Gafencu, B Stoilova, M Buono, Y Zhang, S Turkalj, Y Meng, ...
Science Immunology 9 (98), eadk3469, 2024
62024
Identification and Age-dependent Increase of Platelet Biased Human Hematopoietic Stem Cells
M Aksöz, GA Gafencu, B Stoilova, M Buono, Y Meng, NA Jakobsen, ...
bioRxiv, 2022.01. 14.475546, 2022
62022
GOLD NANOPARTICLES CONJUGATED WITH RITUXIMAB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA.
S Boca, C Lucan, I Frinc, B Petrushev, T SIMON, C Berce, GA Gafencu, ...
Farmacia 64 (5), 2016
62016
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
S Iluta, S Pasca, G Gafencu, A Jurj, A Terec, P Teodorescu, C Selicean, ...
Journal of Cellular and Molecular Medicine 25 (13), 6094-6102, 2021
32021
The impact of ageing on the human haematopoietic stem cell and memory T cell compartments through the lens of single cell transcriptome analysis
GA Gafencu
University of Oxford, 2022
2022
DNMT3A-NPM1 mutated acute myeloid leukaemia shows sensitivity to a PARP1 inhibitor combined with daunorubicin in an in vitro model
G Gafencu, V Pileczki, A Jurj, L Magdo, C Selicean, R Ola, G Ghiaur, ...
bioRxiv, 362103, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–19